Drug
Sovateltide
Sovateltide: highest development phase Phase 3, developed by Pharmazz, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pharmazz, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sovateltide NCT05691244 | Phase 3 | Acute Ischemic Stroke |
Latest
No recent events.
Follow Sovateltide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.